Skip to main navigation Skip to search Skip to main content

Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier oncology group GI06-101

  • E. Gabriela Chiorean
  • , Rashmi Ramasubbaiah
  • , Menggang Yu
  • , Joel Picus
  • , Jose A. Bufill
  • , Yan Tong
  • , Nicki Coleman
  • , Erica L. Johnston
  • , Colleen Currie
  • , Patrick J. Loehrer

Research output: Contribution to journal › Article › peer-review

66   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier oncology group GI06-101'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science